Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 7846 AL 7860

Intranasal insulin for mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials

Silva AMP, Gonçalves OR, Tudella GCN, Nascimento MVS, Pereira MAOM, Nantes LAO, Fernandes JVA, Quiroga DG, Lima DVS Jr, Franco ES, Maia MBS.

Rev Neurol (Paris). 2026 Jan-Feb;182(1-2):36-48. doi: 10.1016/j.neurol.2025.11.005. Epub 2025 Dec 22.

Older adults living with Alzheimer's Disease, dementia or mild cognitive impairment with no informal caregiver or care partner: IDEA Café, the first pilot randomized trial intervention for this underserved populations

Fredriksen-Goldsen KI, Kim HJ, Teri L, Jones-Cobb BR, Fazia D, Petros R, Berridge C, Prasad A, Oswald A, Emlet CA.

Aging Ment Health. 2025 Aug;29(8):1398-1406. doi: 10.1080/13607863.2025.2468893. Epub 2025 Apr 20.

Study protocol for a randomized controlled trial assessing clinical efficacy of digital cognitive rehabilitation for preclinical and mild clinical stages of alzheimer's disease continuum: the MI-RICORDO project

Blasi V, Isernia S, Rossetto F, Pagliari C, Borgnis F, Pirastru A, Marzulli M, Foglia E, Garagiola E, Baglio F.

BMC Psychiatry. 2025 Nov 11;25(1):1075. doi: 10.1186/s12888-025-07531-7.

Study design and protocol for cognitive anxiety sensitivity treatment for anxiety in adults with mild cognitive impairment or dementia

Markley AE, Stratton KM, Cho GY, Schmidt NB, Suhr J, Sheffler JL, Nguyen C, Schubert FT, Quiles JRG, Potter MR, Meynadasy MA, Irvin SM, Allan NP.

Contemp Clin Trials. 2025 Sep;156:108044. doi: 10.1016/j.cct.2025.108044. Epub 2025 Aug 6.

Daily function outcomes in adults with mild cognitive impairment due to Alzheimer's disease after two years of processing speed training versus a control training protocol

Wadley VG, Zhang Y, Bull T, Barba C, Bolaji Y, Bryan RN, Crowe M, Desiderio L, Erus G, Geldmacher DS, Go R, Lassen-Greene CL, Mamaeva OA, Marson DC, McLaughlin M, Nasrallah IM, Owsley C, Passler J, Perry RT, Pilonieta G, Steward KA, Wood A, Kennedy RE.

J Alzheimers Dis. 2025 Aug;106(3):1130-1142. doi: 10.1177/13872877251351341. Epub 2025 Jun 26.

A systematic review of psychometric properties of questionnaires assessing activities of daily living among older adults with neurocognitive disorders

Osman A, Radman D, Belchior P, Gélinas I.

Aust Occup Ther J. 2025 Feb;72(1):e13013. doi: 10.1111/1440-1630.13013.

Comparative efficacy and safety of different brexpiprazole doses for agitation in Alzheimer's disease: A systematic review and network meta-analysis

Kandeel M, Mahmoud M.

J Alzheimers Dis. 2026 Feb;109(3):1089-1098. doi: 10.1177/13872877251404500. Epub 2025 Dec 8.

IPECAD Modeling Workshop 2023 Cross-Comparison Challenge on Cost-Effectiveness Models in Alzheimer's Disease

Handels R, Herring WL, Kamgar F, Aye S, Tate A, Green C, Gustavsson A, Wimo A, Winblad B, Sköldunger A, Raket LL, Stellick CB, Spackman E, Hlávka J, Wei Y, Mar J, Soto-Gordoa M, de Kok I, Brück C, Anderson R, Pemberton-Ross P, Urbich M, Jönsson L.

Value Health. 2025 Apr;28(4):497-510. doi: 10.1016/j.jval.2024.09.006. Epub 2024 Oct 8.

The dual role of ACE2 in viral infections and neurodegeneration: mechanisms and therapeutic opportunities

Amelimojarad M, Amelimojarad M.

J Neurovirol. 2025 Oct;31(5):397-406. doi: 10.1007/s13365-025-01282-7. Epub 2025 Oct 14.

Efficacy and Safety of Escitalopram and Citalopram for Agitation in Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

da Silva AMP, Falcão L, Virgilio Ribeiro F, Ogasawara Donato K, Machado Magalhães PL, Nascimento MDVS, Leite M, Lee Han M, Quiroga DG, de Souza Franco E, de Sousa Maia MB.

J Geriatr Psychiatry Neurol. 2026 May;39(3):249-260. doi: 10.1177/08919887251369893. Epub 2025 Aug 22.

Efficacy and Safety of Lithium for Behavioral and Cognitive Symptoms in Alzheimer's Disease Dementia: A Systematic Review With Frequentist and Bayesian Meta-Analysis

Pereira da Silva AM, de Deus O, Ribeiro FV, Tudella GCN, Cabeça LS, Silva LL, Han ML, Franco JO, Costa JGP, Santos do Nascimento MDV, Andrade Fernandes JV, Franco ES, de Sousa Maia MB.

Am J Geriatr Psychiatry. 2026 Mar;34(3):371-385. doi: 10.1016/j.jagp.2025.10.001. Epub 2025 Oct 4.

Juxtacortical Lesion Precedes Lobar Microbleed During Anti-amyloid β Immunotherapy

Shindo A, Hirata Y, Tomimoto H.

Intern Med. 2025 Nov 15;64(22):3284-3286. doi: 10.2169/internalmedicine.5198-24. Epub 2025 May 15.

Expert opinion on Centiloid thresholds suitable for initiating anti-amyloid therapy. Summary of discussion at the 2024 spring Alzheimer's Association Research Roundtable

Farrar G, Weber CJ, Rabinovici GD.

J Prev Alzheimers Dis. 2025 Jan;12(1):100008. doi: 10.1016/j.tjpad.2024.100008. Epub 2025 Jan 1.

Efficacy and Safety of Exogenous Ketones in People with Mild Neurocognitive Disorder and Alzheimer's Disease: A Systematic Literature Review

Krolak-Salmon P, Swerdlow RH, Mastain T, Dive-Pouletty C, Pooley N, Kisomi M.

Nutr Rev. 2025 Mar 1;83(3):e1034-e1048. doi: 10.1093/nutrit/nuae098.

Positive Impact of Holistic Nursing on Cognitive Impairment and Psychiatric Symptoms in Patients With Alzheimer's Disease

Yu J, Zhu L, Song Y, Shi B, Zhou X.

Actas Esp Psiquiatr. 2025 May;53(3):586-597. doi: 10.62641/aep.v53i3.1948.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias